Flutter atrial neonatal após inserção de cateter umbilical intracardíaco

Abstract

The association between atrial arrhythmias and misplaced umbilical catheters has been described in the literature, but in this case, it is noteworthy that the patient was an infant born to a diabetic mother, which consists in another risk factor for heart arrhythmias. Isolated atrial flutter is a rare tachyarrhythmia in the neonatal period and its identification is essential to establish early treatment and prevent systemic complications and even death.

Central Venous Catheter-Related Tachycardia in the Newborn: Case Report and Literature Review

“…Understanding the potential for catheter migration and subsequent arrhythmia is also important as time to onset varies. While the majority occur at the time of insertion, arrhythmia can occur hours or even days after insertion (in one case, 47 days after insertion) [6, 9, 11, 12]. This is demonstrated by our case, with migration of the catheter tip implicated in SVT onset more than a day after insertion.…”

“…While tachyarrhythmias are well recognised as a potential complication of central venous catheters in adults, only scattered case reports exist in the neonatal literature [3]. 16 cases of atrial tachyarrhythmia associated with central venous access in neonates are available to review when combined with our case [1, 3–12]. These are presented in Table 1.…”

“…An awareness of this pattern is vital, as atrial flutter in a non-catheter-related context is less common than SVT and thus potentially prone to underrecognition [3]. Promptly and accurately distinguishing the type of arrhythmia is particularly important as treatment differs, with synchronised cardioversion for atrial flutter versus intravenous adenosine for SVT [1, 3–10, 12]. …”

II Jornada Integrada da Faculdade Santa Maria

“…Além disso, pessoas do sexo feminino tem naturalmente uma tendência maior em apresentar problemas mentais, por serem mais susceptíveis a transtornos de ordem emocional. As mulheres também apresentam uma menor resistência em relatar os problemas mentais ao médico, quando comparadas aos homens, que, na maioria dos casos, omitem sintomas, impossibilitando o diagnóstico dos transtornos mentais e, consequentemente, a prescrição de psicotrópicos (MOURA et al, 2016). Dos 41 indivíduos que fazem ou já fez uso de medicamentos psicotrópicos, a maioria (31%) tem ente 41 e 50 anos de idade, 26% tem entre 51 e 60 anos e apenas uma minoria (10%) possuem mais de 60 anos de idade.…”

“…Os psicotrópicos, também conhecidos como psicofármacos, são substâncias químicas que atuam no Sistema Nervoso Central (SNC), promovendo alterações de comportamento, humor e pensamento. Tais medicamentos devem ser prescritos a pacientes portadores de transtornos psíquicos, podendo possuir ação antidepressiva, ansiolítica e/ou anticonvulsivante, com capacidade de induzir dependência, mesmo em baixas doses (MOURA et al, 2016).…”